| SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic A Figueroa-Romero, A Atchadé, A Yadouleton, M Fiogbe, E Bonnet, ... BMC Public Health 24 (1), 1762, 2024 | | 2024 |
| Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised … R González, T Nhampossa, G Mombo-Ngoma, J Mischlinger, M Esen, ... The Lancet Infectious Diseases 24 (5), 476-487, 2024 | 6 | 2024 |
| Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy: review of evidence J Recht, R Clark, R González, S Dellicour World Health Organization, 2024 | | 2024 |
| Does acute malnutrition in young children increase the risk of treatment failure following artemisinin-based combination therapy? A WWARN individual patient data meta-analysis K Stepniewska, R Allan, AR Anvikar, TA Anyorigiya, EA Ashley, Q Bassat, ... The Lancet Global Health 12 (4), e631-e640, 2024 | | 2024 |
| Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps A Figueroa-Romero, A Saura-Lázaro, S Fernández-Luis, R González The Lancet HIV, 2024 | | 2024 |
| Efficacy and safety of hydroxychloroquine for treatment of mild SARS‐CoV‐2 infection and prevention of COVID‐19 severity in pregnant and postpartum women: A randomized, double … R González, A Goncé, MM Gil, E Mazarico, E Ferriols‐Pérez, P Toro, ... Acta Obstetricia et Gynecologica Scandinavica 103 (3), 602-610, 2024 | | 2024 |
| Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone M Wassenaar, AE Fombah, H Chen, K Owusu-Kyei, J Williams, ... BMC Public Health 24 (1), 143, 2024 | 2 | 2024 |
| PA-296 Intermittent preventive treatment (IPT) of malaria in pregnancy with mefloquine may reduce nevirapine levels among HIV-infected women L Stoeger, A Valá, E Sevene, M Brunet, A Nhacolo, E Macete, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PA-443 A decade of trends in HIV infection among pregnant women in southern Mozambique A Muxlhanga, R González, A Nhacolo, A Figueroa, MM Mazuze, A Mayor, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| OA-99 Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: a multi-centre … R González, T Nhampossa, G Mombo-Ngoma, J Mischlinger, M Esen, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PA-574 Prevalence and factors associated with malaria infection in children aged 10 to 23 months in Togo in 2022 MK Tchankoni, S Arikawa, FA Gbeasor-Komlanvi, AJ Sadio, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PA-466 Factors associated with coverage of three doses of intermittent preventive treatment of malaria in infants with Sulfadoxine-pyrimethamine: a cross-sectional community … AE Fombah, H Chen, K Owusu-Kyei, L Quinto, R Gonzalez, J Williams, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PA-142 High SARS-CoV-2 seroprevalence among pregnant women in Allada and Natitingou (Benin) in 2022 A Figueroa-Romero, A Atchadé, A Yadouleton, M Fiogbe, E Bonnet, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Prevalence and risk factors associated with malaria infection in children under two years of age in southern Togo prior to perennial malaria chemoprevention implementation S Arikawa, MK Tchankoni, FA Gbeasor-Komlanvi, SP Atekpe, ... Malaria Journal 22 (1), 357, 2023 | 4 | 2023 |
| Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in … A Figueroa-Romero, D Bissombolo, M Meremikwu, A Ratsimbasoa, ... The Lancet global health 11 (11), e1765-e1774, 2023 | 2 | 2023 |
| Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a … M Djimde, JK Tshiongo, HM Muhindo, H Tinto, E Sevene, M Traore, ... BMJ open 13 (10), e065295, 2023 | 1 | 2023 |
| Séroprévalence de l'infection à SARS-CoV-2 chez la femme enceinte à Allada et Natitingou (Bénin) en 2022 A Figueroa-Romero, A Atchade, M Fiogbe, A Yadouleton, JY Le Hesran, ... Revue d'Épidémiologie et de Santé Publique 71, 101867, 2023 | | 2023 |
| A Case of Undiagnosed Schizophrenia With Catatonia in a Hispanic Adolescent: The Significance of Social Determinants in the Diagnosis and the Efficacy of Risperidone and … S Tedesco, R Gonzalez, P Owusu-Antwi, RE Robinson, C Janusz Cureus 15 (7), 2023 | | 2023 |
| Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic … L Cirera, C Sacoor, M Meremikwu, L Ranaivo, MF Manun’Ebo, ... BMJ Global Health 8 (7), e010238, 2023 | 1 | 2023 |
| Prevalence of and risk factors for microscopic and submicroscopic malaria infections in pregnancy: a systematic review and meta-analysis AM van Eijk, K Stepniewska, J Hill, SM Taylor, SJ Rogerson, G Cottrell, ... The Lancet Global Health 11 (7), e1061-e1074, 2023 | 8 | 2023 |
